Related references
Note: Only part of the references are listed.Interaction with the heparin-derived binding inhibitors destabilizes galectin-3 protein structure
Paulina Sindrewicz et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2020)
Enhanced anti-tumor and anti-metastasis therapy for triple negative breast cancer by CD44 receptor-targeted hybrid self-delivery micelles
Yiliang Yang et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2020)
Pathogenesis and management of heparin-induced thrombocytopenia and thrombosis
Pan Zhou et al.
CLINICA CHIMICA ACTA (2020)
Randomised phase 3 study of adjuvant chemotherapy with or without nadroparin in patients with completely resected non-small-cell lung cancer: the NVALT-8 study
Harry J. M. Groen et al.
BRITISH JOURNAL OF CANCER (2019)
Perfusion of Porcine Kidneys With Macromolecular Heparin Reduces Early Ischemia Reperfusion Injury
Amir Sedigh et al.
TRANSPLANTATION (2019)
Unfractionated Heparin Alleviates Human Lung Endothelial Barrier Dysfunction Induced by High Mobility Group Box 1 Through Regulation of P38-GSK3β-Snail Signaling Pathway
Zhenggang Luan et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2018)
Low incidence of heparin-induced skin lesions in orthopedic surgery patients with low-molecular-weight heparins
M. Schindewolf et al.
CLINICAL AND EXPERIMENTAL ALLERGY (2018)
Anti-tumour effect of low molecular weight heparin in localised lung cancer: a phase III clinical trial
Guy Meyer et al.
EUROPEAN RESPIRATORY JOURNAL (2018)
American Society of Hematology 2018 guidelines for management of venous thromboembolism: heparin-induced thrombocytopenia
Adam Cuker et al.
BLOOD ADVANCES (2018)
Dabigatran enhances platelet reactivity and platelet thrombin receptor expression in patients with atrial fibrillation
A. Achilles et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2017)
Inhibition of inflammation induced shedding of the endothelial glycocalyx with low molecular weight heparin
Herbert H. Lipowsky et al.
MICROVASCULAR RESEARCH (2017)
Heparin antagonizes cisplatin resistance of A2780 ovarian cancer cells by affecting the Wnt signaling pathway
Daniel Bastian Pfankuchen et al.
Oncotarget (2017)
Characterization of PF4-Heparin Complexes by Photon Correlation Spectroscopy and Zeta Potential
Sabrina Bertini et al.
CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS (2017)
Inhibition of plasmin generation in plasma by heparin, low molecular weight heparin, and a covalent antithrombin-heparin complex
Gabriela M. T. Chang et al.
BLOOD COAGULATION & FIBRINOLYSIS (2017)
Old and new applications of non-anticoagulant heparin
Giuseppe Cassinelli et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2016)
Low molecular weight heparin and cancer survival: clinical trials and experimental mechanisms
Ning Zhang et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2016)
Adjuvant therapy with heparin in patients with lung cancer without indication for anticoagulants: A systematic review of the literature with meta-analysis
Yuman Yu et al.
JOURNAL OF CANCER RESEARCH AND THERAPEUTICS (2016)
Randomized Phase III Trial of Standard Therapy Plus Low Molecular Weight Heparin in Patients With Lung Cancer: FRAGMATIC Trial
Fergus Macbeth et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
Neutralisation of the anti-coagulant effects of heparin by histones in blood plasma and purified systems
Colin Longstaff et al.
THROMBOSIS AND HAEMOSTASIS (2016)
Efficacy and safety of low-molecular-weight heparin in patients with sepsis: a meta-analysis of randomized controlled trials
Yu Fan et al.
SCIENTIFIC REPORTS (2016)
Heparin: Past, Present, and Future
Eziafa I. Oduah et al.
PHARMACEUTICALS (2016)
The Efficacy and Safety of Heparin in Patients With Sepsis: A Systematic Review and Metaanalysis
Ryan Zarychanski et al.
CRITICAL CARE MEDICINE (2015)
Effect of unfractionated heparin on endothelial glycocalyx in a septic shock model
S. Yini et al.
ACTA ANAESTHESIOLOGICA SCANDINAVICA (2015)
Antitumor properties of a new non-anticoagulant heparin analog from the mollusk Nodipecten nodosus: Effect on P-selectin, heparanase, metastasis and cellular recruitment
Angelica Maciel Gomes et al.
GLYCOBIOLOGY (2015)
Anti-metastasis efficacy and safety of non-anticoagulant heparin derivative versus low molecular weight heparin in surgical pancreatic cancer models
Reem Alyahya et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2015)
Heparin co-factor II enhances cell motility and promotes metastasis in non-small cell lung cancer
Wei-Yu Liao et al.
JOURNAL OF PATHOLOGY (2015)
Low Molecular Weight Heparin (LMWH) Improves Peritoneal Function and Inhibits Peritoneal Fibrosis Possibly through Suppression of HIF-1α, VEGF and TGF-β1
Juan Li et al.
PLOS ONE (2015)
Enoxaparin Sensitizes Human Non-Small-Cell Lung Carcinomas to Gefitinib by Inhibiting DOCK1 Expression, Vimentin Phosphorylation, and Akt Activation
Yan Pan et al.
MOLECULAR PHARMACOLOGY (2015)
Nonanticoagulant heparin prevents histone-mediated cytotoxicity in vitro and improves survival in sepsis
Karin C. A. A. Wildhagen et al.
BLOOD (2014)
Treatment of Low Molecular Weight Heparin Inhibits Systemic Inflammation and Prevents Endotoxin-Induced Acute Lung Injury in Rats
Zheng-Gang Luan et al.
INFLAMMATION (2014)
Heparan Sulfates Mediate the Interaction between Platelet Endothelial Cell Adhesion Molecule-1 (PECAM-1) and the Gαq/11 Subunits of Heterotrimeric G Proteins
Nathaniel G. dela Paz et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2014)
The effect of low molecular weight heparin on survival in cancer patients: an updated systematic review and meta-analysis of randomized trials
D. Sanford et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2014)
Heparan sulfate in the nucleus and its control of cellular functions
Mark D. Stewart et al.
MATRIX BIOLOGY (2014)
Selective Interaction of Heparin with the Variable Region 3 within Surface Glycoprotein of Laboratory-Adapted Feline Immunodeficiency Virus
Qiong-Ying Hu et al.
PLOS ONE (2014)
The role of VLA-4 binding for experimental melanoma metastasis and its inhibition by heparin
Martin Schlesinger et al.
THROMBOSIS RESEARCH (2014)
Clinical Outcomes Associated With the Early Postoperative Use of Heparin in Pancreas Transplantation
Jenna L. Scheffert et al.
TRANSPLANTATION (2014)
Low anticoagulant heparin blocks thrombin-induced endothelial permeability in a PAR-dependent manner
Joyce N. Gonzales et al.
VASCULAR PHARMACOLOGY (2014)
Heparin therapy reduces 28-day mortality in adult severe sepsis patients: a systematic review and meta-analysis
Changsong Wang et al.
CRITICAL CARE (2014)
The accumulation of circulating histones on heparan sulphate in the capillary glycocalyx of the lungs
Craig G. Freeman et al.
BIOMATERIALS (2013)
Evolution of heparin anticoagulants to ultra-low-molecular-weight heparins: A review of pharmacologic and clinical differences and applications in patients with cancer
Jeanine M. Walenga et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2013)
Unfractionated Heparin Ameliorates Lipopolysaccharide-Induced Lung Inflammation by Downregulating Nuclear Factor-κB Signaling Pathway
Xu Li et al.
INFLAMMATION (2013)
Inhibition of smooth muscle cell adhesion and proliferation on heparin-doped polypyrrole
E. M. Stewart et al.
ACTA BIOMATERIALIA (2012)
Unfractionated heparin inhibits lipopolysaccharide-induced inflammatory response through blocking p38 MAPK and NF-κB activation on endothelial cell
Xu Li et al.
CYTOKINE (2012)
Modulating the interaction of CXCR4 and CXCL12 by low-molecular-weight heparin inhibits hepatic metastasis of colon cancer
Lixin Ma et al.
INVESTIGATIONAL NEW DRUGS (2012)
Monocytes, neutrophils, and platelets cooperate to initiate and propagate venous thrombosis in mice in vivo
Marie-Luise von Bruehl et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2012)
A randomized trial of dalteparin compared with ibuprofen for the treatment of superficial thrombophlebitis
S. W. Rathbun et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2012)
Neutrophil Extracellular Traps Directly Induce Epithelial and Endothelial Cell Death: A Predominant Role of Histones
Mona Saffarzadeh et al.
PLOS ONE (2012)
Low molecular weight heparin downregulates tissue factor expression and activity by modulating growth factor receptor-mediated induction of nuclear factor-κB
Camille Ettelaie et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2011)
Crosstalk of reactive oxygen species and NF-kappa B signaling
Michael J. Morgan et al.
CELL RESEARCH (2011)
Mast Cells Increase Vascular Permeability by Heparin-Initiated Bradykinin Formation In Vivo
Chris Oschatz et al.
IMMUNITY (2011)
Individual patient data meta-analysis of enoxaparin vs. unfractionated heparin for venous thromboembolism prevention in medical patients
S. Laporte et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2011)
Heparin-associated anti-Xa activity and platelet-derived prothrombotic and proinflammatory biomarkers in moderate to high-risk patients with acute coronary syndrome
Richard C. Becker et al.
JOURNAL OF THROMBOSIS AND THROMBOLYSIS (2011)
MECHANISMS OF DISEASE The Hemostatic System as a Modulator of Atherosclerosis
Julian Ilcheff Borissoff et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Glycosaminoglycans as polyelectrolytes
Emek Seyrek et al.
ADVANCES IN COLLOID AND INTERFACE SCIENCE (2010)
Enoxaparin Improves the Course of Dextran Sodium Sulfate-Induced Colitis in Syndecan-1-Deficient Mice
Martin Floer et al.
AMERICAN JOURNAL OF PATHOLOGY (2010)
Bradykinin forming capacity of oversulfated chondroitin sulfate contaminated heparin in vitro
Albert Adam et al.
BIOMATERIALS (2010)
Inflammation and coagulation
Marcel Levi et al.
CRITICAL CARE MEDICINE (2010)
Low-molecular-weight heparin-induced osteoporosis and osteoporotic fractures: A myth or an existing entity?
E. Lefkou et al.
LUPUS (2010)
Antimetastatic activities of heparins and modified heparins. Experimental evidence
Lubor Borsig
THROMBOSIS RESEARCH (2010)
Heparin-based nanoparticles
Melissa M. Kemp et al.
WILEY INTERDISCIPLINARY REVIEWS-NANOMEDICINE AND NANOBIOTECHNOLOGY (2010)
Fondaparinux versus Enoxaparin in non-ST-elevation acute coronary syndromes: Short-term cost and long-term cost-effectiveness using data from the Fifth Organization to Assess Strategies in Acute Ischemic Syndromes Investigators (OASIS-5) trial
Mark J. Sculpher et al.
AMERICAN HEART JOURNAL (2009)
Chemically Modified Heparin Inhibits In Vitro L-Selectin-Mediated Human Ovarian Carcinoma Cell Adhesion
Zhihong Chen et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2009)
Platelet endothelial cell adhesion molecule 1 (PECAM-1) and its interactions with glycosaminoglycans: 2. Biochemical analyses
Deirdre R. Coombe et al.
BIOCHEMISTRY (2008)
The effect of dalteparin, a kind of low molecular weight heparin, on lung adenocarcinoma A549 cell line in vitro
Xiaojun Chen et al.
CANCER INVESTIGATION (2008)
INCREASED LEVELS OF GLYCOSAMINOGLYCANS DURING SEPTIC SHOCK: RELATION TO MORTALITY AND THE ANTIBACTERIAL ACTIONS OF PLASMA
Axel Nelson et al.
SHOCK (2008)
Linear diffusion of thrombin and factor Xa along the heparin molecule explains the effects of extended heparin chain lengths
Rob Wagenvoord et al.
THROMBOSIS RESEARCH (2008)
The role of tissue factor pathway inhibitor in tumor growth and metastasis
Ali Amirkhosravi et al.
SEMINARS IN THROMBOSIS AND HEMOSTASIS (2007)
A meta-analysis and systematic review of the efficacy and safety of anticoagulants as cancer treatment - Impact on survival and bleeding complications
Nicole M. Kuderer et al.
CANCER (2007)
Extracellular RNA constitutes a natural procoagulant cofactor in blood coagulation
Christian Kannemeier et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Heparin attenuates metastasis mainly due to inhibition of P- and L-selectin, but non-anticoagulant heparins can have additional effects
Jennifer L. Stevenson et al.
THROMBOSIS RESEARCH (2007)
Mechanisms of heparin induced anti-cancer activity in experimental cancer models
T. M. H. Niers et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2007)
Heparin inhibits NF-kappa B activation and increases cell death in cerebral endothelial cells after oxygen-glucose deprivation
Jeong Ho Lee et al.
JOURNAL OF MOLECULAR NEUROSCIENCE (2007)
Low-molecular weight and unfractionated heparins induce a downregulation of inflammation:: decreased levels of proinflammatory cytokines and nuclear factor-κB in LPS-stimulated human monocytes
H Hochart et al.
BRITISH JOURNAL OF HAEMATOLOGY (2006)
The ability of different forms of heparins to suppress P-selectin function in vitro correlates to their inhibitory capacity on bloodborne metastasis in vivo
RJ Ludwig et al.
THROMBOSIS AND HAEMOSTASIS (2006)
Polyphosphate modulates blood coagulation and fibrinolysis
SA Smith et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Improved coagulation in bleeding disorders by non-anticoagulant sulfated polysaccharides (NASP)
TY Liu et al.
THROMBOSIS AND HAEMOSTASIS (2006)
Some structural determinants of the antiproliferative effect of heparin-like molecules on human airway smooth muscle
V Kanabar et al.
BRITISH JOURNAL OF PHARMACOLOGY (2005)
Endothelial heparan sulfate deficiency impairs L-selectin- and chemokine-mediated neutrophil trafficking during inflammatory responses
LC Wang et al.
NATURE IMMUNOLOGY (2005)
Randomized comparison of low molecular weight heparin and coumarin derivatives on the survival of patients with cancer and venous thromboembolism
AYY Lee et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
The effect of low molecular weight heparin on survival in patients with advanced malignancy
CPW Klerk et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Molecular weight determination of heparin and dermatan sulfate by size exclusion chromatography with a triple detector array
S Bertini et al.
BIOMACROMOLECULES (2005)
Neutrophil extracellular traps kill bacteria
V Brinkmann et al.
SCIENCE (2004)
Structure of the antithrombin-thrombin-heparin ternary complex reveals the antithrombotic mechanism of heparin
W Li et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2004)
Fibroblast growth factor 2 endocytosis in endothelial cells proceed via syndecan-4-dependent activation of Rac1 and a Cdc42-dependent macropinocytic pathway
E Tkachenko et al.
JOURNAL OF CELL SCIENCE (2004)
Altered inactivation pathway of factor Va by activated protein C in the presence of heparin
GAF Nicolaes et al.
EUROPEAN JOURNAL OF BIOCHEMISTRY (2004)
Low molecular weight heparin, therapy with dalteparin, and survival in advanced cancer: The fragmin advanced malignancy outcome study (FAMOUS)
AK Kakkar et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
Effect of enoxaparin on high glucose-induced activation of endothelial cells
I Manduteanu et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2003)
The inhibition of blood coagulation by heparins of different molecular weight is caused by a common functional motif -: the C-domain
R Al Dieri et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2003)
Molecular determinants of the mechanism underlying acceleration of the interaction between antithrombin and factor Xa by heparin pentasaccharide
NS Quinsey et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Minimal heparin/heparan sulfate sequences for binding to fibroblast growth factor-1
M Guerrini et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2002)
Novel drug development opportunities for heparin
R Lever et al.
NATURE REVIEWS DRUG DISCOVERY (2002)
Differential effects of heparin saccharides on the formation of specific fibroblast growth factor (FGF) and FGF receptor complexes
O Ostrovsky et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Low molecular weight heparin inhibits tumor necrosis factor α-induced leukocyte rolling
MX Wan et al.
INFLAMMATION RESEARCH (2001)
Intranasal heparin reduces eosinophil recruitment after nasal allergen challenge in patients with allergic rhinitis
C Vancheri et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2001)
The BBXB motif of RANTES is the principal site for heparin binding and controls receptor selectivity
AEI Proudfoot et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Nebulized heparin in Burkholderia cepacia colonized adult cystic fibrosis patients
M Ledson et al.
EUROPEAN RESPIRATORY JOURNAL (2001)
Heparin and low-molecular-weight heparin - Mechanisms of action, pharmacokinetics, dosing, monitoring, efficacy, and safety
J Hirsh et al.
CHEST (2001)
Thrombin signalling and protease-activated receptors
SR Coughlin
NATURE (2000)
The effects of heparin and related molecules upon the adhesion of human polymorphonuclear leucocytes to vascular endothelium in vitro
R Lever et al.
BRITISH JOURNAL OF PHARMACOLOGY (2000)
Share Paper
